Australian Pharmaceutical IndustriesFollow
Australian Pharmaceutical Industries Archives
Sigma Healthcare looks to sweep up its rival before Wesfarmers can create its new division.
API reports $4.0 billion in revenue for FY19 as flagship health and beauty retailer sees like-for-like sales return to g...
CEO Richard Vincent said API is no rush to sell its Sigma shares.